跳至主要内容
临床试验/NCT00387803
NCT00387803已完成2 期

VENTAK CHF/CONTAK CD Biventricular Pacing Study

Boston Scientific Corporation2 个研究点 分布在 1 个国家目标入组 581 人开始时间: 1998年2月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
581
试验地点
2
主要终点
Composite of all-cause mortality, heart failure hospitalization, and ventricular tachyarrhythmia

研究概览

简要总结

The purpose of this study was to determine if cardiac resynchronization therapy when combined with defibrillation is safe and effective in the treatment of symptomatic heart failure.

详细描述

Patients enrolled received a device with cardiac resynchronization therapy (CRT) and defibrillation. Patients were randomized to CRT on or off for up to six months and evaluated for mortality, hospitalization, and functional outcomes including exercise capacity, quality of life, symptomatic status, and echocardiographic analysis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

性别
All
接受健康志愿者

入选标准

  • Symptomatic heart failure
  • Left ventricular ejection fraction <= 35%
  • QRS width >= 120 ms
  • Indicated for an implantable cardioverter defibrillator

排除标准

  • Indicated for a pacemaker
  • Atrial tachyarrhythmias

结局指标

主要结局

Composite of all-cause mortality, heart failure hospitalization, and ventricular tachyarrhythmia

次要结局

  • Peak VO2
  • NYHA Class
  • Six minute walk distance
  • Quality of life
  • Echocardiographic measures

研究者

申办方类型
Industry

研究点 (2)

Loading locations...

相似试验